Literature DB >> 8446034

Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells.

E Papini1, M Bugnoli, M De Bernard, N Figura, R Rappuoli, C Montecucco.   

Abstract

Bafilomycin A1, a specific inhibitor of the vacuolar-type H(+)-ATPase, responsible for acidification of intracellular compartments, prevents the vacuolization of Hela cells induced by H. pylori, with an inhibitory concentration giving 50% of maximal (ID50) of 4 nM. Bafilomycin A1 is also very efficient in restoring vacuolated cells to a normal appearance. The vacuolating activity of Helicobacter pylori is not inhibited by a series of specific inhibitors of vacuolar H(+)-ATPases. These findings indicate that a transmembrane pH gradient is needed for the formation and growth of vacuoles caused by the bacterium and that this pH gradient is due to the activity of a vacuolar ATPase proton pump of HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446034     DOI: 10.1111/j.1365-2958.1993.tb01123.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  37 in total

1.  The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH.

Authors:  D M Czajkowsky; H Iwamoto; T L Cover; Z Shao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Exploitation of the endocytic pathway by Orientia tsutsugamushi in nonprofessional phagocytes.

Authors:  Hyuk Chu; Jung-Hee Lee; Seung-Hoon Han; Se-Yoon Kim; Nam-Hyuk Cho; Ik-Sang Kim; Myung-Sik Choi
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Deletion of the major proteolytic site of the Helicobacter pylori cytotoxin does not influence toxin activity but favors assembly of the toxin into hexameric structures.

Authors:  D Burroni; P Lupetti; C Pagliaccia; J M Reyrat; R Dallai; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Binding of the Helicobacter pylori vacuolating cytotoxin to target cells.

Authors:  P Massari; R Manetti; D Burroni; S Nuti; N Norais; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

5.  Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells.

Authors:  D T Smoot; J H Resau; M H Earlington; M Simpson; T L Cover
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

6.  Bafilomycin A1 and intracellular multiplication of Legionella pneumophila.

Authors:  L Cattani; P Goldoni; M C Pastoris; L Sinibaldi; N Orsi
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin.

Authors:  E Papini; B Satin; N Norais; M de Bernard; J L Telford; R Rappuoli; C Montecucco
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies.

Authors:  R Manetti; P Massari; D Burroni; M de Bernard; A Marchini; R Olivieri; E Papini; C Montecucco; R Rappuoli; J L Telford
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 9.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

10.  Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.

Authors:  Masaaki Nakayama; Junzo Hisatsune; Eiki Yamasaki; Hajime Isomoto; Hisao Kurazono; Masanori Hatakeyama; Takeshi Azuma; Yoshio Yamaoka; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  J Biol Chem       Date:  2008-11-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.